Leuven Tolerogenic Protocol for Intestinal Transplantation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

An immunomodulatory protocol, experimentally-proven to promote T-regulatory dependent graft protective mechanisms was applied in a clinical cohort of 13 intestinal transplant recipients to activate - in a protolerogenic environment - T-regulatory cells.

This protocol is the standard of care in the investigators intestinal transplant programme since the first intestinal transplant was performed in october 2000.

Eligibility criteria

Qualifiers

all patients awaiting intestinal transplantation

Disqualifiers

living donation

Trial design

Treatments tested in this trial

  • intestinal transplantation

Treatment groups

13 Participants
are divided into 1 treatment group